Latest News

Alphamab Oncology to Present Multiple Clinical Research Data at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021)

SUZHOU, China, May 20, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced, data from three clinical studies of the PD-L1/CTLA-4 bispecific antibody KN046 will be presented in Poster session at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO 2021) to be held...

2021-05-20 09:34 9103

Huawei Helps E-Commerce Platform Realise Mobile Potential with Brand New Petal Merchant Centre

SINGAPORE, May 20, 2021 /PRNewswire/ -- During eTail Asia, the virtual summit & expo forAsia's leading participants in e-commerce and digital marketing, Huawei Mobile Services' (HMS) native search engine – Petal Search, introduced the new Petal Merchant Centre (PMC), a platform designed to suppor...

2021-05-20 09:30 2867

Premium Struts and Shocks brand PRT already making waves after SEA launch

BUFORD, Ga. and SINGAPORE, May 20, 2021 /PRNewswire/ -- Shortly after debuting inSoutheast Asia, automotive struts and shock absorbers manufacturer PRT (Performance Ride Technology) inSoutheast Asia, is already garnering strong interest from dealers and distributors with its OEM-quality parts tha...

2021-05-20 09:03 5881

Kids2 Brands Now Available to All Families in China

Expansion Furthers Goal to Provide Parenting Solutions to Families Across the Globe ATLANTA, May 20, 2021 /PRNewswire/ -- Kids2, a global company that designs solutions to help early-stage parents and families, today announces the availability of their portfolio of brands,Baby Einstein, Bright S...

2021-05-20 09:00 2697

Yalla Group Limited Responds to Short Attack Reports

DUBAI, UAE, May 19, 2021 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the leading voice-centric social networking and entertainment platform in theMiddle East and North Africa (MENA), today announced that it became aware of certain short attack reports that contain...

2021-05-20 09:00 13090

ASCO 2021 | Ascentage Pharma to Announce Updated Data of Lisaftoclax (APG-2575) Demonstrating an ORR of Around 80% and Therapeutic Potential in Patients with R/R CLL/SLL in Oral Presentation

SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that an abstract reporting on...

2021-05-20 08:44 5362

Quantitative Brokers Launches Agency Execution Algo Suite for Bursa Malaysia Derivatives in the Latest Step in QB's APAC Expansion

Focus on Crude Palm Oil, KCLI Futures SYDNEY, May 20, 2021 /PRNewswire/ -- Quantitative Brokers (QB), a leading provider of advanced execution algorithms and data-driven analytics for global futures and options markets, today launched their suite of award-winning execution algorithms on Bursa Ma...

2021-05-20 08:30 4121

ASCO 2021 | Ascentage Pharma to Announce Updated Results Demonstrating Clinical Potential of Alrizomadlin (APG-115) Plus Pembrolizumab in Patients with Advanced Solid Tumors that Had Failed Immunotherapies in Oral Presentation

SUZHOU, China and ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that abstracts reporting on t...

2021-05-20 08:17 5718

Limited Edition Book Featuring The Ultimate Collection of Patek Philippe Vintage Watches Launched in Singapore

SINGAPORE, May 20, 2021 /PRNewswire/ -- The Patek Philippe – My Dream Collection  was launched on April 21 by Singapore based watch collector and Patek Philippe aficionado,Ali Nael, founder of 2tonevintage, with a limited production run of 500 copies. The limited edition book features over 120 ...

2021-05-20 08:10 26224

L'OCCITANE to take centre stage at the IUCN Congress to contribute to a 'nature-positive' world

GENEVA, May 20, 2021 /PRNewswire/ -- The L'OCCITANE Group, a leading manufacturer and retailer of beauty and well-being products rich in natural and organic ingredients and a pioneer in corporate sustainability, is pleased to announce that it will participate in the IUCN World Conservation Congre...

2021-05-20 08:00 2611

RevLifter Brings eCommerce Solutions to APAC with Launch of Hong Kong Office

Trailblazing eCommerce technology looks to meet region's demand for hyper-personalized deals and offers with local presence LONDON and HONG KONG, May 20, 2021 /PRNewswire/ -- RevLifter , the technology provider transforming eCommerce growth rates through hyper-persona...

2021-05-20 08:00 2953

'Investment in Second Citizenship is an Investment in You,' Says Head of Dominica's Citizenship by Investment Unit

LONDON, May 20, 2021 /PRNewswire/ -- At the China Offshore Summit 2021 in Beijing this week, the Head of the Dominica Citizenship by Investment Unit, AmbassadorEmmanuel Nanthan, invited investors and their families in China to become citizens ofDominica. China Offshore is a media company that pro...

2021-05-20 08:00 2449

Transcenta Announced the Results of the Phase I Clinical Study of PD-L1 Antibody MSB2311 with Advanced Solid Tumors and Hematological Malignancies

SUZHOU, China, May 20, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced that the updated Phase I clinical study (NCT04272944) d...

2021-05-20 08:00 2750

PeopleStrong, poised for 3X growth from HR Tech, expands to Australia & New Zealand

MELBOURNE, Australia, May 20, 2021 /PRNewswire/ -- PeopleStrong , Asia's leading Enterprise HR Technology company expands toAustralia and New Zealand markets with SaaS based, AI enabled HR solutions that range from applicant tracking & recruitment technology to ...

2021-05-20 08:00 1879

Duality Biologics Completed $90 Million Series B Financing

PRINCETON, N.J. and SHANGHAI and SUZHOU, China, May 19, 2021 /PRNewswire/ -- Duality Biologics (DualityBio or Company), an innovative biotech company, announced the completion of$90 million series B financing today. This round of financing was led by Lilly Asia Ventures (LAV) and jointly invested...

2021-05-20 08:00 1988

Future Thailand - Innovation in Education and Workforce Development

Stanford Thailand Research Consortium Panel Discussion to Address Skills Gap in Workforce Development STANFORD, Calif., May 20, 2021 /PRNewswire/ -- The Innovative Teaching Scholars (ITS) program, a key research initiative of the Stanford Thailand Research Consortium (STRC), will share its progr...

2021-05-20 07:00 1961

Swydo Founder Buys Back Digital Marketing Platform From DialogTech

Former Google Benelux Country Director Marc Duijndam Joins As Co-Owner, Helps Initiate Renewed Focus On Growth And Innovation HILVERSUM, Netherlands, May 20, 2021 /PRNewswire/ -- Swydo, a global leader for digital marketing dashboards, reports and visualizations announced today the buyback of th...

2021-05-20 07:00 2349

World Brain Day 2021 Dedicated to Multiple Sclerosis

World Federation of Neurology partners with the MS International Federation to promote Multiple Sclerosis awareness on World Brain Day LONDON, May 20, 2021 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announce that the theme of this year's World Brain Day is Stop Multipl...

2021-05-20 07:00 1604

4.5 Billion Parcels Expanded Market Share to 20.4%

Adjusted Net Income Increased 23.1% to Reach RMB781.6 Million ZTO Reports First Quarter 2021 Unaudited Financial Results SHANGHAI, May 20, 2021 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057), a leading and fast-growing express delivery company in China ("ZTO" or the "Compan...

2021-05-20 06:00 11485

I-Mab Presents Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021

* Uliledlimab is a highly differentiated CD73 antibody with a unique epitope that confers pharmacological advantages * Data from U.S. phase 1 dose escalation trial demonstrates favorable safety and tolerability with no dose-limiting toxicities; preliminary clinical activity of uliledlimab has...

2021-05-20 06:00 8634

Week's Top Stories